These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25 related articles for article (PubMed ID: 27476454)
1. Investigation of the relationship between topology and selectivity for druglike molecules. Yang Y; Chen H; Nilsson I; Muresan S; Engkvist O J Med Chem; 2010 Nov; 53(21):7709-14. PubMed ID: 20942392 [TBL] [Abstract][Full Text] [Related]
2. Efficient total synthesis of novel bioactive microbial metabolites. Sunazuka T; Hirose T; Omura S Acc Chem Res; 2008 Feb; 41(2):302-14. PubMed ID: 18217720 [TBL] [Abstract][Full Text] [Related]
3. Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds. Tyrchan C; Blomberg N; Engkvist O; Kogej T; Muresan S Bioorg Med Chem Lett; 2009 Dec; 19(24):6943-7. PubMed ID: 19879759 [TBL] [Abstract][Full Text] [Related]
4. Bilinear Model for the Size-Dependency of the CYP3A4 Inhibitory Activity of Structurally Diverse Compounds. Buchwald P; Yamashita F Mol Inform; 2014 Jan; 33(1):8-14. PubMed ID: 27485194 [TBL] [Abstract][Full Text] [Related]
5. Design of a general-purpose European compound screening library for EU-OPENSCREEN. Horvath D; Lisurek M; Rupp B; Kühne R; Specker E; von Kries J; Rognan D; Andersson CD; Almqvist F; Elofsson M; Enqvist PA; Gustavsson AL; Remez N; Mestres J; Marcou G; Varnek A; Hibert M; Quintana J; Frank R ChemMedChem; 2014 Oct; 9(10):2309-26. PubMed ID: 25044981 [TBL] [Abstract][Full Text] [Related]
6. Computational identification of bioactive natural products by structure activity relationship. Zhou X; Li Y; Chen X J Mol Graph Model; 2010 Aug; 29(1):38-45. PubMed ID: 20488738 [TBL] [Abstract][Full Text] [Related]
7. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Meanwell NA Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149 [TBL] [Abstract][Full Text] [Related]
8. Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds. Yang Y; Engkvist O; Llinàs A; Chen H J Med Chem; 2012 Apr; 55(8):3667-77. PubMed ID: 22443161 [TBL] [Abstract][Full Text] [Related]
9. Lasso peptides: an intriguing class of bacterial natural products. Hegemann JD; Zimmermann M; Xie X; Marahiel MA Acc Chem Res; 2015 Jul; 48(7):1909-19. PubMed ID: 26079760 [TBL] [Abstract][Full Text] [Related]
10. An Investigation of the Relationship Between Molecular Topology and CYP3A4 Inhibition for Drug-like Compounds. Oka R; Engkvist O; Chen H Mol Inform; 2012 Oct; 31(10):719-23. PubMed ID: 27476454 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the influence of molecular topology on ligand binding. Oka R; Engkvist O; Chen H J Mol Graph Model; 2013 Mar; 40():22-9. PubMed ID: 23353581 [TBL] [Abstract][Full Text] [Related]
12. Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules. Chen H; Yang Y; Engkvist O J Chem Inf Model; 2010 Dec; 50(12):2141-50. PubMed ID: 21077637 [TBL] [Abstract][Full Text] [Related]